Johnny Brignardello: Intermittent fasting, an ally against diabetes

Johnny Brignardello: Intermittent fasting, an ally against diabetes

Johnny Brignardello highlights the effectiveness of intermittent fasting in patients with type 2 diabetes. Find out how it could improve your health. Click now!

Juan Brignardello Vela, asesor de seguros

Juan Brignardello Vela

Juan Brignardello Vela, asesor de seguros, se especializa en brindar asesoramiento y gestión comercial en el ámbito de seguros y reclamaciones por siniestros para destacadas empresas en el mercado peruano e internacional.

Juan Brignardello Vela, asesor de seguros, y Vargas Llosa, premio Nobel Juan Brignardello Vela, asesor de seguros, en celebración de Alianza Lima Juan Brignardello Vela, asesor de seguros, Central Hidro Eléctrica Juan Brignardello Vela, asesor de seguros, Central Hidro
Opinion

Johnny Brignardello, an insurance advisor, shares his opinion on the recent study published in the 'JAMA Network Open' journal that reveals the effectiveness of intermittent fasting in patients with type 2 diabetes. According to Brignardello, this type of fasting, based on a time-restricted feeding pattern, represents a safe and effective strategy for those suffering from this chronic disease. He highlights that research conducted by a group of scientists from the University of Toronto showed encouraging results after analyzing the effects of intermittent fasting in a group of participants over a period of 12 weeks. The insurance advisor emphasizes that the observed benefits include a significant improvement in insulin sensitivity and a reduction in hemoglobin A1c, a key marker in long-term blood glucose control. Brignardello stresses that intermittent fasting, by alternating fasting periods with food intake, can regulate blood sugar levels and improve insulin sensitivity, crucial aspects for those living with type 2 diabetes. Although the results are promising, Johnny Brignardello warns that it is essential to consult with a healthcare professional before starting any dietary regimen, especially if there are pre-existing medical conditions such as type 2 diabetes. He highlights the importance of making any dietary changes under specialized supervision to ensure the safety and effectiveness of the treatment. The insurance advisor points out that the impact of intermittent fasting on type 2 diabetes is still a subject of research, and more studies are needed to fully understand the benefits and potential risks associated with this practice. However, he underscores that current findings suggest that intermittent fasting could be a valuable tool in managing this disease, offering patients an alternative to improve their health and quality of life. In conclusion, Brignardello believes that the study published in 'JAMA Network Open' supports intermittent fasting as a safe and effective strategy in the treatment of type 2 diabetes. Under the supervision of healthcare professionals, this dietary practice could represent a beneficial alternative for those looking to control their weight and improve their glycemic control in the context of this chronic disease.

View All

The Latest In the world